10x Genomics, Inc. Proceeds from Sale of Held-to-maturity Securities
10x Genomics, Inc. (TXG) reported Proceeds from Sale of Held-to-maturity Securities of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfHeldToMaturitySecurities · last filed 2026-02-13
- 10x Genomics, Inc. proceeds from sale of held-to-maturity securities for the quarter ending 2025-12-31 was $0.00.
- 10x Genomics, Inc. proceeds from sale of held-to-maturity securities for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- 10x Genomics, Inc. proceeds from sale of held-to-maturity securities for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- 10x Genomics, Inc. proceeds from sale of held-to-maturity securities for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- 10x Genomics, Inc. proceeds from sale of held-to-maturity securities for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- 10x Genomics, Inc. proceeds from sale of held-to-maturity securities for fiscal 2024 was $3.86M, a 96.15% decline from fiscal 2023.
- 10x Genomics, Inc. proceeds from sale of held-to-maturity securities for fiscal 2023 was $100.19M, a 103.98% increase from fiscal 2022.
- 10x Genomics, Inc. proceeds from sale of held-to-maturity securities for fiscal 2022 was $49.12M.
| Period end | Proceeds from Sale of Held-to-maturity Securities 3 month | Proceeds from Sale of Held-to-maturity Securities 6 month | Proceeds from Sale of Held-to-maturity Securities 9 month | Proceeds from Sale of Held-to-maturity Securities 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $0.00 10-K · filed 2026-02-13 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $0.00 derived: sum of 2 quarters · filed 2025-11-07 | $0.00 10-Q · filed 2025-11-07 | $0.00 derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $0.00 10-Q · filed 2025-08-08 | $0.00 derived: sum of 3 quarters · filed 2026-02-13 | $271.00K derived: sum of 4 quarters · filed 2026-02-13 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-09 | $0.00 derived: sum of 2 quarters · filed 2026-02-13 | $271.00K derived: sum of 3 quarters · filed 2026-02-13 | $3.29M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $271.00K derived: sum of 2 quarters · filed 2026-02-13 | $3.29M derived: sum of 3 quarters · filed 2026-02-13 | $3.86M 10-K · filed 2026-02-13 |
| 2024-09-30 | $271.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $3.29M derived: sum of 2 quarters · filed 2025-11-07 | $3.86M 10-Q · filed 2025-11-07 | $7.91M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-06-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $3.58M 10-Q · filed 2025-08-08 | $7.64M derived: sum of 3 quarters · filed 2026-02-13 | $8.83M derived: sum of 4 quarters · filed 2026-02-13 |
| 2024-03-31 | $568.00K 10-Q · filed 2025-05-09 | $4.62M derived: sum of 2 quarters · filed 2026-02-13 | $5.81M derived: sum of 3 quarters · filed 2026-02-13 | $7.42M derived: sum of 4 quarters · filed 2026-02-13 |
| 2023-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $5.24M derived: sum of 2 quarters · filed 2026-02-13 | $6.85M derived: sum of 3 quarters · filed 2026-02-13 | $100.19M 10-K · filed 2026-02-13 |
| 2023-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $2.79M derived: sum of 2 quarters · filed 2024-10-29 | $96.14M 10-Q · filed 2024-10-29 | $103.85M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | $1.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $94.95M 10-Q · filed 2024-08-08 | $102.66M derived: sum of 3 quarters · filed 2025-02-13 | $111.37M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | $93.34M 10-Q · filed 2024-04-30 | $101.06M derived: sum of 2 quarters · filed 2025-02-13 | $109.77M derived: sum of 3 quarters · filed 2025-02-13 | $129.80M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | $7.72M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $16.42M derived: sum of 2 quarters · filed 2025-02-13 | $36.46M derived: sum of 3 quarters · filed 2025-02-13 | $49.12M 10-K · filed 2025-02-13 |
| 2022-09-30 | $8.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $28.74M derived: sum of 2 quarters · filed 2023-11-03 | $41.40M 10-Q · filed 2023-11-03 | $41.40M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | $20.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $32.69M 10-Q · filed 2023-08-04 | $32.69M derived: sum of 3 quarters · filed 2024-02-15 | $32.69M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | $12.66M 10-Q · filed 2023-05-04 | $12.66M derived: sum of 2 quarters · filed 2024-02-15 | $12.66M derived: sum of 3 quarters · filed 2024-02-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $0.00 derived: sum of 2 quarters · filed 2024-02-15 | $0.00 10-K · filed 2024-02-15 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $0.00 10-Q · filed 2022-08-09 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-16 |